Table 2.

Expression of CD94/NKG2C is unrelated to HSV or EBV serology


Serologic status*

No.

% CD94/NKG2C+

P
HCMV    
   Negative   34   0.3 ± 0.4   < .001  
   0.2 (0.1-1.7)   
   Positive   34   3.5 ± 4.4   
   2.2 (0.1-22.3)   
HSV    
   Negative   8   3.0 ± 4.8   .39  
   0.6 (0.1-11)   
   Positive   23   1.5 ± 2.1   
   0.3 (0.1-6.5)   
EBV    
   Negative   6   3.4 ± 4.1   .21  
   1.9 (0.1-10.4)   
   Positive   25   1.5 ± 2.6   

 

 
0.2 (0.1-11)
 

 

Serologic status*

No.

% CD94/NKG2C+

P
HCMV    
   Negative   34   0.3 ± 0.4   < .001  
   0.2 (0.1-1.7)   
   Positive   34   3.5 ± 4.4   
   2.2 (0.1-22.3)   
HSV    
   Negative   8   3.0 ± 4.8   .39  
   0.6 (0.1-11)   
   Positive   23   1.5 ± 2.1   
   0.3 (0.1-6.5)   
EBV    
   Negative   6   3.4 ± 4.1   .21  
   1.9 (0.1-10.4)   
   Positive   25   1.5 ± 2.6   

 

 
0.2 (0.1-11)
 

 
*

Detection of serum IgG specific for HCMV, HSV, and EBV

NKG2C+ PBLs were defined by flow cytometry. Expressed as mean ± SD and median (range)

Analysis according to the Mann-Whitney U test

Close Modal

or Create an Account

Close Modal
Close Modal